•How to post a question? 
•To log in again if the connection is lost, use the link in the confirmation mailer you would have received from gotowebinar@citrixonline.com 
•In case you face any other issues write an email to puneet.ramaul@beroe-inc.com
Angad Singh 
Senior Research Analyst 
Beroe-Inc 
Dialing in from: 
India 
Host 
Members for the Webinar 
Shriram 
Engagement Manager 
Beroe-Inc 
Dialing in from: 
India 
Moderator
01 
Demand scenario 
02 
Demand management 
03 
Justify the Monopolistic Control 
04 
How Buyer Side Procurement can Counter the Monopoly
33 
34 
35 
36 
37 
38 
39 
2012 
2015 (F) 
Loss in Billion USD 
Patent 
Expiries 
Opportunity Loss Comparison – 2012 vs 2015(F) 
38 
Patent Cliff
Growing Emphasis on Reducing Healthcare Costs 
Generics 
Inflation
Increased dependency on secondary market research 
Spend Of 10-50 million USD on secondary market research 
On an average, 60-70% of this amount is spent “on the monopolistic provider” 
Patients, Payers & Prescriber 
Competitor Landscape & Drug Positioning
Increased dependency on secondary market research 
Market 
New Market Same Product 
New Market New Product 
Same Market Same Product 
Same Market New Product 
Product 
 
 
 
? 
Data Insights 
Pharma Consultants
Patent Cliff in 2011-2012 
35 Billion 
Increased demand for secondary market research services 
Individual company opportunity loss as high as 6.1 billion USD 
On an average 3 billion USD for top pharmaceutical organizations
Recovering from the Economic Slowdown 
Service Providers Unable to Sustain 
Stakeholder Facing Budgetary Cuts 
Innovative Procurement Trend – Single Base Service Provider Dependency 
Win-win Situation 
Assured Revenue Influx 
Accommodating Budgetary Cuts
Attracted More Client Portfolio's 
Buyer’s Constraints 
Budget Cuts (Minimum of 3% – 5%) 
Supply Risk – Financial Instability of Service Providers 
Service Provider’s Leveraging Points 
Operated on Low Profit Margins 
As low as 
7-10% 
Financial Stability 
Overall Revenue 
USD 2.1 Billion 
Capability to Service Across Geographies 
Organic expansions 
New business units 
Research Revenue 
USD 750 Million 
Net Profit 
USD 311 Million 
Inorganic expansions 
M&A
Highlights 
Ownership For Outsourcing was on the Service Provider 
RFI & RFQ Process 
On-site Support 
Global Contracts 
Services at Competitive Prices 
Spend Consolidation 
Continuous Revenue Influx 
Captive Working Model – FTE Basis
YES!! 
North America 
Suppliers – 40-50 
Latin America 
Suppliers – 25-30 
Europe 
Suppliers – 40-50 
APAC 
Suppliers – 75-100 
Africa 
Suppliers – 10-20
Globally, About 160 – 170 Service Providers Competing Across “The Perceived Giant’s” Service Lines 
Cost of services is 10%-15% lower 
100 
75 
50 
Service Provider 1 
Service Provider 2 
0 
25 
55-65% 
65-70% 
2/3 Demand
Step by step de-bundling of services 
Identify markets with presence of alternates 
Initial phase 
Phase I 
Engage with alternatives on short term basis 
Phase II 
Engage with preferred service providers on long term basis 
Evaluation Phase 
Review performance of service providers 
Service like payer insights, patent insights, prescriber insights, patient & physician insights 
Key market like US, UK, France, Germany, Pharmemerging markets 
•Here the contract duration may range from 3 months to 1 year 
•Evaluate & filter out service providers 
•Long term 2-3 years 
•Parallel engagement would ensure a platform to benchmark services 
•Value Benefits Provided 
•Accuracy of Insights 
•Ease of Integration
•Ability to bring in service innovation or onboard technology to meet buyer’s business objectives 
•Measured Based on Database Synchronization, Refresh Rate, Server Downtime 
•Preferential pay-back terms, ability to work on a pay-for- performance model 
Value Benefits Provided 
Accuracy of Insights 
Ease of Integration
Market Leader Buying out Competition 
1 
Relative Value/Profit Impact 
Market Risk Complexity 
Critical 
Acquisition 
Leverage 
Strategic 
Low 
High 
High 
Shifting Balance towards Supplier 
Low 
Possibility is Low 
Amount of competition in the market is HIGH
Increased Sourcing Complexity 
2 
Center-led Procurement Structure 
Business Unit 1 
Business Unit 2 
Business Unit 1 Category Director 
Business Unit 2 Category Director 
CPO 
Corporate Purchasing 
Centralized procurement with regional corporate control
Increased Harmonization Costs 
3 
De-bundle up to (60-70)% 
Implies 5%-10% saving on purchasing secondary market research services 
On time investment on harmonization cost would be 
3%-5% of the spend 
“Realize cost savings from second year itself”
Leverage Value Benefits 
•Implement pay-for- performance pricing mode 
•Free ad-hoc projects 
Create Supplier Competition 
•Parallel sourcing – monopolistic service provider & alternatives 
Reduced Supply Risk 
•Evaluation of untapped supply base 
Higher Negotiating Power 
•Discounts on pricing points 
•Preferential service provider fee payment terms 
Pros
Increase 
Sourcing 
complexity 
Increased 
Harmonization 
Costs 
Keep in Mind 
•Increased service provider base 
•Multiple contract management 
•Internal re-structuring 
•Service providers & procurement team synergies
“Change is inevitable” 
The time to evaluate alternative providers is “NOW!!”

Secondary market research

  • 2.
    •How to posta question? •To log in again if the connection is lost, use the link in the confirmation mailer you would have received from gotowebinar@citrixonline.com •In case you face any other issues write an email to puneet.ramaul@beroe-inc.com
  • 3.
    Angad Singh SeniorResearch Analyst Beroe-Inc Dialing in from: India Host Members for the Webinar Shriram Engagement Manager Beroe-Inc Dialing in from: India Moderator
  • 5.
    01 Demand scenario 02 Demand management 03 Justify the Monopolistic Control 04 How Buyer Side Procurement can Counter the Monopoly
  • 6.
    33 34 35 36 37 38 39 2012 2015 (F) Loss in Billion USD Patent Expiries Opportunity Loss Comparison – 2012 vs 2015(F) 38 Patent Cliff
  • 7.
    Growing Emphasis onReducing Healthcare Costs Generics Inflation
  • 8.
    Increased dependency onsecondary market research Spend Of 10-50 million USD on secondary market research On an average, 60-70% of this amount is spent “on the monopolistic provider” Patients, Payers & Prescriber Competitor Landscape & Drug Positioning
  • 9.
    Increased dependency onsecondary market research Market New Market Same Product New Market New Product Same Market Same Product Same Market New Product Product    ? Data Insights Pharma Consultants
  • 10.
    Patent Cliff in2011-2012 35 Billion Increased demand for secondary market research services Individual company opportunity loss as high as 6.1 billion USD On an average 3 billion USD for top pharmaceutical organizations
  • 11.
    Recovering from theEconomic Slowdown Service Providers Unable to Sustain Stakeholder Facing Budgetary Cuts Innovative Procurement Trend – Single Base Service Provider Dependency Win-win Situation Assured Revenue Influx Accommodating Budgetary Cuts
  • 12.
    Attracted More ClientPortfolio's Buyer’s Constraints Budget Cuts (Minimum of 3% – 5%) Supply Risk – Financial Instability of Service Providers Service Provider’s Leveraging Points Operated on Low Profit Margins As low as 7-10% Financial Stability Overall Revenue USD 2.1 Billion Capability to Service Across Geographies Organic expansions New business units Research Revenue USD 750 Million Net Profit USD 311 Million Inorganic expansions M&A
  • 13.
    Highlights Ownership ForOutsourcing was on the Service Provider RFI & RFQ Process On-site Support Global Contracts Services at Competitive Prices Spend Consolidation Continuous Revenue Influx Captive Working Model – FTE Basis
  • 14.
    YES!! North America Suppliers – 40-50 Latin America Suppliers – 25-30 Europe Suppliers – 40-50 APAC Suppliers – 75-100 Africa Suppliers – 10-20
  • 15.
    Globally, About 160– 170 Service Providers Competing Across “The Perceived Giant’s” Service Lines Cost of services is 10%-15% lower 100 75 50 Service Provider 1 Service Provider 2 0 25 55-65% 65-70% 2/3 Demand
  • 16.
    Step by stepde-bundling of services Identify markets with presence of alternates Initial phase Phase I Engage with alternatives on short term basis Phase II Engage with preferred service providers on long term basis Evaluation Phase Review performance of service providers Service like payer insights, patent insights, prescriber insights, patient & physician insights Key market like US, UK, France, Germany, Pharmemerging markets •Here the contract duration may range from 3 months to 1 year •Evaluate & filter out service providers •Long term 2-3 years •Parallel engagement would ensure a platform to benchmark services •Value Benefits Provided •Accuracy of Insights •Ease of Integration
  • 17.
    •Ability to bringin service innovation or onboard technology to meet buyer’s business objectives •Measured Based on Database Synchronization, Refresh Rate, Server Downtime •Preferential pay-back terms, ability to work on a pay-for- performance model Value Benefits Provided Accuracy of Insights Ease of Integration
  • 18.
    Market Leader Buyingout Competition 1 Relative Value/Profit Impact Market Risk Complexity Critical Acquisition Leverage Strategic Low High High Shifting Balance towards Supplier Low Possibility is Low Amount of competition in the market is HIGH
  • 19.
    Increased Sourcing Complexity 2 Center-led Procurement Structure Business Unit 1 Business Unit 2 Business Unit 1 Category Director Business Unit 2 Category Director CPO Corporate Purchasing Centralized procurement with regional corporate control
  • 20.
    Increased Harmonization Costs 3 De-bundle up to (60-70)% Implies 5%-10% saving on purchasing secondary market research services On time investment on harmonization cost would be 3%-5% of the spend “Realize cost savings from second year itself”
  • 21.
    Leverage Value Benefits •Implement pay-for- performance pricing mode •Free ad-hoc projects Create Supplier Competition •Parallel sourcing – monopolistic service provider & alternatives Reduced Supply Risk •Evaluation of untapped supply base Higher Negotiating Power •Discounts on pricing points •Preferential service provider fee payment terms Pros
  • 22.
    Increase Sourcing complexity Increased Harmonization Costs Keep in Mind •Increased service provider base •Multiple contract management •Internal re-structuring •Service providers & procurement team synergies
  • 23.
    “Change is inevitable” The time to evaluate alternative providers is “NOW!!”